A
ArteraAI
AI NativeArteraAI is a precision-medicine company that generates prognostic and predictive insights from digitized pathology images combined with clinical data to support treatment selection and risk stratification in localized prostate cancer.
Est 2021|Valuation $400M|Raised $109.5M